Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00906737 · ClinicalTrials.gov registry record · NA

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

A NA study of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT00906737 is a NA study of Multiple Sclerosis that has completed, run by Mount Sinai Rehabilitation Hospital. The registered enrollment target is 18 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00906737, a NA study of Multiple Sclerosis, has completed, sponsored by Mount Sinai Rehabilitation Hospital.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused ankle therapy in improving the gait of subjects with MS.

Conditions Studied

Interventions

  • DEVICE Ankle-bot
  • OTHER Conventional focused ankle therapy

Study Locations (1)

Connecticut

  • Mandell Center for Multiple Sclerosis at Mount Sinai Rehabilitation Hospital - Hartford

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2009-04
Est. Completion 2012-04
Phase NA

What the Registry Record Tells You About NCT00906737

The ClinicalTrials.gov registry entry for NCT00906737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Mount Sinai Rehabilitation Hospital, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Ankle-bot is the first listed.

NCT00906737 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00906737 about?

NCT00906737 is a clinical study titled "Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities". This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused...

What is the current status of trial NCT00906737?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2009-04. Estimated completion is 2012-04.

What conditions does trial NCT00906737 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT00906737?

The interventions under investigation include: Ankle-bot (DEVICE), Conventional focused ankle therapy (OTHER).

Who is sponsoring clinical trial NCT00906737?

This trial is sponsored by Mount Sinai Rehabilitation Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00906737 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.